Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Avolio

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Clinical Science (London, England : 1979)|November 22, 2021
The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular diseaseElisa Avolio, Michele Carrabba, Rachel Milligan, et al.
European Journal of Heart Failure|May 9, 2020
Transfer of a human gene variant associated with exceptional longevity improves cardiac function in obese type 2 diabetic mice through induction of the SDF-1/CXCR4 signalling pathwayZexu Dang, Elisa Avolio, Anita C Thomas, et al.
Cardiovascular Research|January 12, 2023
The longevity-associated BPIFB4 gene supports cardiac function and vascularization in ageing cardiomyopathyMonica Cattaneo, Antonio P Beltrami, Anita C Thomas, et al.
Stem Cells (Dayton, Ohio)|May 8, 2014
Ex vivo molecular rejuvenation improves the therapeutic activity of senescent human cardiac stem cells in a mouse model of myocardial infarctionElisa Avolio, Giuseppe Gianfranceschi, Daniela Cesselli, et al.
Circulation Research|March 25, 2015
Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repairElisa Avolio, Marco Meloni, Helen L Spencer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 26, 2019
Role of TPBG (Trophoblast Glycoprotein) Antigen in Human Pericyte Migratory and Angiogenic ActivityHelen L Spencer, Eva Jover, William Cathery, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 10, 2015
Epigenetic profile of human adventitial progenitor cells correlates with therapeutic outcomes in a mouse model of limb ischemiaMiriam Gubernator, Sadie C Slater, Helen L Spencer, et al.
Cell Death & Disease|August 15, 2023
BPIFB4 and its longevity-associated haplotype protect from cardiac ischemia in humans and miceMonica Cattaneo, Aneta Aleksova, Alberto Malovini, et al.
Journal of the American Heart Association|January 24, 2018
Transplantation of Allogeneic Pericytes Improves Myocardial Vascularization and Reduces Interstitial Fibrosis in a Swine Model of Reperfused Acute Myocardial InfarctionValeria Vincenza Alvino, Rodrigo Fernández-Jiménez, Iker Rodriguez-Arabaolaza, et al.
Journal of the American Heart Association|June 18, 2015
Expansion and characterization of neonatal cardiac pericytes provides a novel cellular option for tissue engineering in congenital heart diseaseElisa Avolio, Iker Rodriguez-Arabaolaza, Helen L Spencer, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Clinical Science (London, England : 1979)|November 22, 2021
The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular diseaseElisa Avolio, Michele Carrabba, Rachel Milligan, et al.
European Journal of Heart Failure|May 9, 2020
Transfer of a human gene variant associated with exceptional longevity improves cardiac function in obese type 2 diabetic mice through induction of the SDF-1/CXCR4 signalling pathwayZexu Dang, Elisa Avolio, Anita C Thomas, et al.
Cardiovascular Research|January 12, 2023
The longevity-associated BPIFB4 gene supports cardiac function and vascularization in ageing cardiomyopathyMonica Cattaneo, Antonio P Beltrami, Anita C Thomas, et al.
Stem Cells (Dayton, Ohio)|May 8, 2014
Ex vivo molecular rejuvenation improves the therapeutic activity of senescent human cardiac stem cells in a mouse model of myocardial infarctionElisa Avolio, Giuseppe Gianfranceschi, Daniela Cesselli, et al.
Circulation Research|March 25, 2015
Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repairElisa Avolio, Marco Meloni, Helen L Spencer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 26, 2019
Role of TPBG (Trophoblast Glycoprotein) Antigen in Human Pericyte Migratory and Angiogenic ActivityHelen L Spencer, Eva Jover, William Cathery, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 10, 2015
Epigenetic profile of human adventitial progenitor cells correlates with therapeutic outcomes in a mouse model of limb ischemiaMiriam Gubernator, Sadie C Slater, Helen L Spencer, et al.
Cell Death & Disease|August 15, 2023
BPIFB4 and its longevity-associated haplotype protect from cardiac ischemia in humans and miceMonica Cattaneo, Aneta Aleksova, Alberto Malovini, et al.
Journal of the American Heart Association|January 24, 2018
Transplantation of Allogeneic Pericytes Improves Myocardial Vascularization and Reduces Interstitial Fibrosis in a Swine Model of Reperfused Acute Myocardial InfarctionValeria Vincenza Alvino, Rodrigo Fernández-Jiménez, Iker Rodriguez-Arabaolaza, et al.
Journal of the American Heart Association|June 18, 2015
Expansion and characterization of neonatal cardiac pericytes provides a novel cellular option for tissue engineering in congenital heart diseaseElisa Avolio, Iker Rodriguez-Arabaolaza, Helen L Spencer, et al.
Pageof 4